A Multi Region Neurodegenerative Changes in Methamphetamine Dependence Reveal by Magnetic Resonance Spectroscopy: A Psychological Aspects
Authors
-
Javad Sheikhi Kouhsar 1
1. School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
http://orcid.org/0000-0003-2425-6265
-
Fariborz Faeghi 1
1. School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
http://orcid.org/0000-0002-5132-3577
-
Hamaid Kalalian Moghadam 2*
2. School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran.
http://orcid.org/0000-0002-8342-919X
DOI:
https://doi.org/10.22100/ijhs.v7i1.823Keywords:
Methamphetamine, Abstinence, Neurodegeneration, Magnetic Resonance Spectroscopy, Dopamine, circuitAbstract
Background: Methamphetamine (METH) is an illicit psychostimulant that is widely abused in the world. Several lines of evidence suggest that chronic METH abuse leads to neurodegenerative changes in the human brain. These include damage to dopamine and serotonin axons, loss of gray matter accompanied by hypertrophy of the white matter, and microgliosis in different brain areas.
Methods: Magnetic resonance spectroscopy measures of N-acetyl aspartate (NAA), Creatine (Cre), Choline (Cho), Myo-inositol (Ml), were obtained in the dopamine circuit (Ventral Tegmental Area, Nucleus Accumbens, Substantia nigra, Striatum, Frontal Cortex, Hippocampus) of the brain in participants in 30 abstinent methamphetamine-addicted people with psychosis (METHp+), and 10 healthy controls (HCs) (age ranges of 18 to 50 years old). Psychotic symptoms were assessed with the Positive and Negative Syndrome Scale (PANSS) and analyzed using a five-factor model. All participants were also assessed for physical and mental illnesses as well as recent substance use.
Results: The METHp+ group displayed robust alteration in basic metabolite concentration levels (NAA, cho, Cr, mI, and GLX) relative to HCs. This suggests that cellular metabolism is altered in both conditions but in METHp+ group is seeing more dramatic changes. Significant decrease in the concentration of NAA metabolites (mean of 18.56) in the methamphetamine group with high psychological symptoms (mean of 111.9) in the studied areas compared to the control group which is a neurotransmitter and biomarker, indicates chronic neurological degeneration in the test areas and its relationship with the incidence of mental disorders in these individuals (Pvalue<0.01).
Conclusions: These data support the assumption that cellular abnormalities differ between methamphetamine addiction psychosis and healthy controls people despite not different in normal imaging acquisition.
Keywords: Methamphetamine, Abstinence, Neurodegeneration, Magnetic Resonance Spectroscopy, Dopamine circuit.
References
2-Sung, Young Hoon Yurgelun-Todd, Deborah A. Shi, Xian Feng et al. Decreased frontal lobe phosphocreatine levels in methamphetamine users. Drug and Alcohol Dependence. 2013
3-Grant, Kathleen M. LeVan, Tricia D. Wells, Sandra M et al. Methamphetamine-associated psychosis. Journal of Neuroimmune Pharmacology. 2012
4-Glasner-Edwards, Suzette Mooney, Larissa J. Methamphetamine psychosis: Epidemiology and management. CNS Drugs. 2014
5-Oz, Gülin Alger, Jeffry R Barker, Peter B et al. Clinical proton MR spectroscopy in central nervous system disorders. Radiology. 2014
6-Berman, Steven O'Neill, Joseph Fears, Scott et al. Abuse of amphetamines and structural abnormalities in the brain. Annals of the New York Academy of Sciences. 2008
7-Jeong, Hyeonseok S. Lee, Sunho Yoon, Sujung et al. Morphometric abnormalities of the lateral ventricles in methamphetamine-dependent subjects. Drug and Alcohol Dependence. 2013
8-Courtney, Kelly E. Ray, Lara A. Methamphetamine: An update on epidemiology, pharmacology, clinical phenomenology, and treatment literature. Drug and Alcohol Dependence. 2014;143,1:11-21
9-Salo, Ruth Buonocore, Michael H. Leamon, Martin Natsuaki, Yutaka Waters, Christy Moore, Charles D. Galloway, Gantt P. Nordahl, Thomas E. Extended findings of brain metabolite normalization in MA-dependent subjects across sustained abstinence: A proton MRS study. Drug and Alcohol Dependence. 2011;113. 2-3:133-138
10-Salo, Ruth Nordahl, Thomas E. Possin, Kate Leamon, Martin Gibson, David R. Galloway, Gantt P. Flynn, Neil M. Henik, Avishai Pfefferbaum, Adolfa. Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals. Psychiatry Resaearch. 2002;111,1:65-74
11-Salo, Ruth Nordahl, Thomas E Natsuaki, Yutaka Leamon, Martin H. Galloway, Gantt P. Waters, Moore, Charles D. Buonocore, Michael H Christy. Attentional Control and Brain Metabolite Leavels in Methamphetamine Abusers. Biological Psychiatry. 2007; 61, 11: 1272-1280
12-Crocker, Candice E. Bernier, Denise C. Hanstock, Christopher C. Lakusta, Bonnie Purdon, Scot E. Prefrontal glutamate levels differentiate early phase schizophrenia and methamphetamine addiction: A 1H MRS study at 3 TeslaSeres. Schizophrenia Research. 2014;157,1-3:233-237
13-Howells, Fleur M. Uhlmann, Anne Temmingh, Henk Sinclair, Heidi Meintjes, Ernesta Wilson, Don Stein, Dan J. 1H-magnetic resonance spectroscopy (1H-MRS) in methamphetamine dependence and methamphetamine induced psychosis. Schizophrenia Research. 2014;153,1-3:122-128
14-Yu, ShaobinZhu, LingShen, QiangBai, XueDi, XuhuiRecent. advances in methamphetamine neurotoxicity mechanisms and its molecular pathophysiology. Behavioural Neurology. 2015
15-Hamakawa, Hiroshi, Kato, T. shioiri et al. Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder. Psychological Medicine. 1999
16-Sekine, Yoshimoto Minabe, Yoshio Kawai, Masayoshi Suzuki, Katsuaki et al. Metabolite alterations in basal ganglia associated with methamphetamine-related psychiatric symptoms: A proton MRS study. Neuropsychopharmacology. 2002
17-Nordahl, Thomas E. Salo, Ruth Possin, Kate et al. Low N-acetyl-aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine-dependent subjects: A preliminary proton MRS study. Psychiatry Research – Neuroimaging. 2002
18-Iyo, Masaomi Sekine, Yoshimoto Mori, Norio. Neuromechanism of developing methamphetamine psychosis: A neuroimaging study. Annals of the New York Academy of Sciences. 2004
19-Zickler, By Patrick. Brain Imaging Studies Show Long-Term Damage From Methamphetamine Abuse. Neurocritical Care. 2005
20-Oz, Gülin Alger, Jeffry R Barker, Peter B et al. Clinical proton MR spectroscopy in central nervous system disorders. Radiology. 2014
21-Jimenez, Amy M. Biomarkers for psychosis. General Methods in Biomarker Research and their Applications. 2015
22-London, Edythe D. Kohno, Milky Morales, Angelica M. Ballard, Michael E. Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging. Brain Research. 2015
23-Sailasuta, Napapon Abulseoud, Osama Hernandez, Martha et al. Metabolic abnormalities in abstinent methamphetamine dependent subjects. Substance Abuse: Research and Treatment. 2010
24-Plitman, Eric de la Fuente-Sandoval, Camilo Reyes-Madrigal, Francisco et al. Elevated myo-inositol, choline, and glutamate levels in the associative striatum of antipsychotic-naive patients with first-episode psychosis: A proton magnetic resonance spectroscopy study with implications for glial dysfunction. Schizophrenia Bulletin. 2016
25-Stock, Ann Kathrin Rädle, Marion Beste, Christian. Methamphetamine-associated difficulties in cognitive control allocation may normalize after prolonged abstinence. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2019
Published
Issue
Section
License
The Copyright Form should be downloaded and signed by corresponding author in the fourth step "upload supplementary files" during submission process.
After acceptance, copyright form should be downloaded and signed by all authors one by one ( "summery --> supp. file" part and click on "add a supplementary file" link).
